WHO ICTRP trial

Development of a method for secondary and tertiary prevention of head and neck…

DRKS00032186 · German Clinical Trials Register · Recruiting

Key facts

Trial ID DRKS00032186
Public title Development of a method for secondary and tertiary prevention of head and neck tumors
Scientific title Development of a method for secondary and tertiary prevention of head and neck tumors - OncSaliva
Primary sponsor Universitätsklinikum Jena, Klinik für Hals-, Nasen- und Ohrenheilkunde
Registry German Clinical Trials Register
Recruitment status Recruiting
Study type observational
Countries China;Germany
Conditions Malignant neoplasm of the oral cavity, oropharynx, hypopharynx, larynx C14.8 C10.8 C32.8 C13.8;Overlapping lesion of lip, oral cavity and pharynx;Overlapping lesion of oropharynx;Overlapping lesion of larynx;Overlapping lesion of…
Interventions Group 1: patients with Head neck cancer
Registration date Mar 7, 2023
Target size 100
Registry page drks.de

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations